Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Munger

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Drugs & Aging|October 23, 2010
Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitusMark A Munger
American Journal of Pharmaceutical Education|March 28, 2014
Primary care pharmacists: provision of clinical-decision services in healthcareMark A Munger
P & T : a Peer-Reviewed Journal for Formulary Management|March 10, 2011
Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directionsMark A Munger
Pharmacotherapy|July 26, 2006
Management of acute decompensated heart failure: treatment, controversy, and future directionsMark A Munger
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 25, 2007
New agents for managing hyponatremia in hospitalized patientsMark A Munger
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 12, 2003
Epidemiology and practice patterns of acute decompensated heart failureMark A Munger, Orly Carter
Journal of the American Pharmacists Association : Japha|January 11, 2014
Community pharmacists' occupational satisfaction and stress: a profession in jeopardy? Response to Rodis and UlbrichMark A Munger, Mike Feehan
Journal of the American Pharmacists Association : Japha|April 21, 2004
Atherothrombosis: epidemiology, pathophysiology, and preventionMark A Munger, David W Hawkins
The Annals of Pharmacotherapy|November 22, 2013
Icosapent ethyl for treatment of elevated triglyceride levelsScott D Nelson, Mark A Munger
The Annals of Pharmacotherapy|March 8, 2007
Aliskiren for renin inhibition: a new class of antihypertensivesBenjamin W Van Tassell, Mark A Munger
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Drugs & Aging|October 23, 2010
Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitusMark A Munger
American Journal of Pharmaceutical Education|March 28, 2014
Primary care pharmacists: provision of clinical-decision services in healthcareMark A Munger
P & T : a Peer-Reviewed Journal for Formulary Management|March 10, 2011
Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directionsMark A Munger
Pharmacotherapy|July 26, 2006
Management of acute decompensated heart failure: treatment, controversy, and future directionsMark A Munger
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 25, 2007
New agents for managing hyponatremia in hospitalized patientsMark A Munger
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 12, 2003
Epidemiology and practice patterns of acute decompensated heart failureMark A Munger, Orly Carter
Journal of the American Pharmacists Association : Japha|January 11, 2014
Community pharmacists' occupational satisfaction and stress: a profession in jeopardy? Response to Rodis and UlbrichMark A Munger, Mike Feehan
Journal of the American Pharmacists Association : Japha|April 21, 2004
Atherothrombosis: epidemiology, pathophysiology, and preventionMark A Munger, David W Hawkins
The Annals of Pharmacotherapy|November 22, 2013
Icosapent ethyl for treatment of elevated triglyceride levelsScott D Nelson, Mark A Munger
The Annals of Pharmacotherapy|March 8, 2007
Aliskiren for renin inhibition: a new class of antihypertensivesBenjamin W Van Tassell, Mark A Munger
Pageof 8